Loss of RUNX1 is associated with aggressive lung adenocarcinomas.
Ramsey J, Butnor K, Peng Z, Leclair T, van der Velden J, Stein G, Lian J, Kinsey CM. Loss of RUNX1 is associated with aggressive lung adenocarcinomas. J Cell Physiol. 2018 04; 233(4):3487-3497.